Caring for patients with advanced COPD: beyond the inhalers…

Area of Science:

• Pulmonary Medicine
• Critical Care
• Palliative Care

Background:

• Chronic Obstructive Pulmonary Disease (COPD) significantly impacts millions globally, with advanced stages characterized by severe symptoms like breathlessness, cough, and fatigue.
• Current guidelines emphasize pharmacological treatments, particularly inhaler therapy, yet a comprehensive approach integrating other modalities is crucial for managing symptom burden.

Purpose of the Study:

• To outline a multidisciplinary management strategy for advanced COPD.
• To review various therapeutic options including oxygen therapy, non-invasive ventilation (NIV), and dyspnoea management.
• To discuss interventional treatments such as lung volume reduction and lung transplantation, alongside the role of palliative care.

Main Methods:

• A review synthesizing contributions from pulmonary physicians, cardiothoracic surgeons, and physiotherapists.
• Examination of current evidence and guidelines for oxygen therapy, NIV, pulmonary rehabilitation, surgical/bronchoscopic interventions, lung transplantation, and palliative care.

Main Results:

• Oxygen therapy, when guideline-adherent, improves COPD mortality.
• Evidence for NIV in COPD management is limited, with low-certainty recommendations.
• Pulmonary rehabilitation is effective for dyspnoea management; specific criteria guide decisions for lung volume reduction.
• Lung transplantation requires precise assessment for optimal patient selection.
• Palliative care complements other treatments, focusing on symptom control and quality of life.

Conclusions:

• A multidisciplinary approach integrating medical management, interventional therapies, and palliative care is essential for optimizing the experience of patients with advanced COPD.
• Individualized symptom management, combined with appropriate medication, can significantly improve patient outcomes and quality of life.